mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
2e-06 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
2e-06 |
mRNA |
PLX4720 |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
2e-06 |
mRNA |
Bexarotene |
GDSC1000 |
pan-cancer |
AAC |
0.21 |
4e-06 |
mRNA |
17-AAG |
GDSC1000 |
pan-cancer |
AAC |
0.18 |
8e-06 |
mRNA |
selumetinib:vorinostat (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.21 |
8e-06 |
mRNA |
AZD6244 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
9e-06 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
1e-05 |
mRNA |
dabrafenib |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
1e-05 |
mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
2e-05 |